The Minority-Based Community Clinical Oncology Program (MBCCOP) was initiated in September 1990 to expand the National Cancer Institute's (NCI's) clinical trials network to minority populations.
Institutions, organizations, and/or physician groups that had more than 50% of new cancer patients from minority groups were eligible to participate.
There has been no previous evaluation of the MBCCOP.
This study was designed to describe the early implementation of the MBCCOP and identify the challenges that have emerged in developing a network aimed at increasing the participation of minority populations in clinical trials.
Mots-clés Pascal : Tumeur maligne, Programme sanitaire, Essai clinique, Traitement, Prévention, Accessibilité, Minorité, Etats Unis, Amérique du Nord, Amérique, Homme
Mots-clés Pascal anglais : Malignant tumor, Sanitary program, Clinical trial, Treatment, Prevention, Accessibility, Minority, United States, North America, America, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0150167
Code Inist : 002B04B. Création : 199406.